A pilot trial to assess the efficacy of Argatroban (Argatra) in critically ill patients with heparin resistance

Trial Profile

A pilot trial to assess the efficacy of Argatroban (Argatra) in critically ill patients with heparin resistance

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Nov 2017

At a glance

  • Drugs Argatroban (Primary) ; Heparin
  • Indications Thromboembolism; Thrombosis
  • Focus Therapeutic Use
  • Acronyms ArgHeR
  • Most Recent Events

    • 24 Jun 2016 Status changed from recruiting to completed.
    • 16 Apr 2015 Planned primary completion date changed from 1 Jun 2014 to 1 Jun 2016, as reported by ClinicalTrials.gov.
    • 26 Nov 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01734252).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top